Manejo clínico de la hipertensión arterial pulmonar. Relevancia del ventrículo derecho

Conde, Rafael E; Diez, Mirta; Dueñas, Rubén; Giacomi, Guillermo; Lema, Luis; Lescano, Adrián; Perna, Eduardo R; Zayas Hernández, Nayeli; Perrone, Sergio V.
Medicina (B.Aires) ; 81(4): 624-636, ago. 2021. graf
Artículo en Español | LILACS | ID: biblio-1346516

Documentos relacionados

  1. [Relevance of right ventricle in the clinical management of pulmonary arterial hypertension].
  2. [Targeted therapy for pulmonary arterial hypertension in patients without comorbidities].
  3. [Medication treatment in pulmonary arterial hypertension with comorbidities - Which phenotypes and points to consider].
  4. Early echocardiographic evaluation of right ventricular load adaptability after sequential combination treatment in pulmonary arterial hypertension.
  5. Structural and Hemodynamic Changes of the Right Ventricle in PH-HFpEF.
  6. Influence of Iron Deficiency on Clinical and Haemodynamic Parameters in Pulmonary Arterial Hypertension Cohorts.
  7. Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
  8. Correlation between pulmonary vascular performance and hemodynamics in patients with pulmonary arterial hypertension.
  9. Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri<sup>®</sup>): a prospective, 6-months, open label, observational, non-interventional study.
  10. In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosis.